Abstract
Glanzmann's thrombasthenia is an autosomal recessive disorder characterized by a lack of platelet aggregation due to the absence of platelet glycoprotein IIb and IIIa. Usually, the disease leads to mild hemorrhage but sometimes bleeding is severe enough to be life-threatening. We report the case of a 16-year-old girl, presenting with very severe type 1 Glanzmann's thrombasthenia, successfully treated with an HLA-identical sibling bone marrow transplant (BMT). We also update the clinical and laboratory data of her brother, who had received a BMT 16 years ago for the same disease. In the light of these two cases and two others published in the literature, we discuss the indications for BMT from HLA-identical sibling donors in Glanzmann's thrombasthenia. Alloimmunization against the missing platelet GPIIb/IIIa complex and severity of bleeding episodes may constitute sufficient criteria for allogeneic BMT after careful assessment of the risk-benefit of such a procedure, although this remains exceptional in this disease. Bone Marrow Transplantation (2000) 25, 327–330.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Glanzmann E . Hereditäre hämorrhagische thrombasthenia. Ein beitrag zur pathologie der bluttplattchen Jarbuch der Kinderheilkunde 1918 88: 1–42
Caen J . Glanzmann's thrombasthenia Baillières Clinical Haematology. 1st edn Baillière Tindall: London 1972 pp 383–392
Nurden AT, Caen JP . The different glycoprotein abnormalities in three cases of Glanzmann's thrombasthenia Br J Haematol 1974 28: 253–260
Caen J . Glanzmann's thrombasthenia. In: Caen JP (ed). Baillières Clinical Haematology. 2nd edn Baillières Tindall: London, 1989 5: 609–625
George JN, Caen J, Nurden AT . Glanzmann's thrombasthenia: the spectrum of clinical disease Blood 1990 75: 1383–1395
Bellucci S, Devergie A, Gluckman E et al. Complete correction of Glanzmann's thrombasthenia by allogeneic bone marrow transplantation Br J Haematol 1985 59: 635–641
Johnson A, Goodall AH, Downie CJC et al. Bone marrow transplantation for Glanzmann's thrombasthenia Bone Marrow Transplant 1994 14: 147–150
McColl MD, Gibson BES . Sibling allogeneic bone marrow transplantation in a patient with type I Glanzmann's thrombasthenia Br J Haematol 1997 99: 58–60
Gruel Y, Boizard B, Daffos F et al. Determination of platelet antigens and glycoproteins in the human fetus Blood 1986 68: 488–492
Von Dem Borne A, Verheught F, Oosterhof F et al. A simple immunofluorescence test for the detection of platelet antibodies Br J Haematol 1978 39: 195–207
Kiefel V, Santoso S, Weisheit M, Muller-Eckhardt C . Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies Blood 1987 70: 1722–1726
Kieffer N, Boizard B, Didry D et al. Immunochemical characterization of the platelet specific alloantigen Leka. A comparative study with the PLA1 alloantigen Blood 1984 64: 1212–1219
Boval B, Dupuy E, Bellucci S et al. Quantification of platelet glycoproteins is a useful index to evaluate platelet transfusion recovery in patients with thrombopathies Transfus Med 1996 6: 174–178
Boizard B, Wautier JL, Caen J . Detection des anticorps antiplaquettes dans le purpura thrombopénique Actualités Hématologiques de l'Hôpital St Louis 1980 14: 164–171
Storb R, Deeg HJ, Whitehead J et al. Methotrexate and cyclosporin compared with cyclosporin alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia New Engl J Med 1986 314: 729–735
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bellucci, S., Damaj, G., Boval, B. et al. Bone marrow transplantation in severe Glanzmann's thrombasthenia with antiplatelet alloimmunization. Bone Marrow Transplant 25, 327–330 (2000). https://doi.org/10.1038/sj.bmt.1702139
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702139
Keywords
This article is cited by
-
Experience of recombinant-activated factor VII to control bleeding in children with Glanzmann’s thrombasthenia
Comparative Clinical Pathology (2007)